Delivery Order SPE2DB22D2206-SPE2DB25FGU53

Award Date 4/30/25
Potential Completion Date 5/1/25
Potential Value $85K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,651.91 firm-fixed-price delivery order contract is for the supply of 4,568,039,684 units of CELLCEPT 500 MG TABLET 500S, a medication used for organ transplant patients. The contract has an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,920.79, is for the supply of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, identified as SPE2DB20D1100|SPE2DB25FC0K1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract, valued at $11,061.15, is a delivery order for the supply of 4,568,092,149 units of the medication CELLCEPT 500 MG TABLET 100S. The contract is a firm fixed-price arrangement with a performance period through May 1, 2025....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract, valued at $9,377.75, is for the delivery of 4564312523 - CELLCEPT 500 MG TABLET 100S, a prescription medication. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of April...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,342.11 firm fixed-price delivery order contract is for the supply of CELLCEPT 500 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of February 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of CellCept 500mg tablets, a pharmaceutical product used in various medical treatments. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,034.70 and a period of performance through November 5, 2024. It is not designated as a set-aside contract....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract award, valued at $5,432.79, is for the delivery of CELLCEPT 500 MG TABLET 100S and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CELLCEPT 250 MG CAPSULE 100S, a medication used for immunosuppression. The contract has a firm fixed price, a ceiling value of $6,882.30, and a performance period through May 2, 2025. This contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,457.95 firm fixed-price contract is for the supply of CELLCEPT 250 MG CAPSULE 100S, a pharmaceutical product, to support military healthcare programs. The award is not associated with a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, with the ID SPE2DB22D1106|SPE2DB25FDNQ8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,298.88 firm fixed-price delivery order is for the supply of CELLCEPT 250 MG CAPSULE 100S, a medication used in the treatment of various medical conditions. The contract has an ultimate completion date of December 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGU53
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $85,073.04, is for the delivery of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, with a performance period through May 1, 2025. The contract is not set aside for any specific business type.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely one of many such orders placed under the larger IDC, enabling the DLA to procure a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/3/25, 12:42 AM